Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06385470
Status:
RECRUITING
Last Update Posted:
2024-04-26
First Post:
2024-04-22
Brief Title:
Treatment of Cantonese Speakers With Childhood Apraxia of Speech
Sponsor:
The Hong Kong Polytechnic University
Organization:
The Hong Kong Polytechnic University
Study Overview
Official Title:
Treatment of Cantonese Speakers With Childhood Apraxia of Speech
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The proposed study aims to investigate the efficacy of the Dynamic Temporal and Tactile Cueing treatment in Cantonese-English bilingual speakers with childhood apraxia of speech
Detailed Description:
Four CE children with CAS will be recruited and receive two versions of the DTTC treatment ie DTTC in English DTTC-E and DTTC in Cantonese DTTC-C After the initial assessment and baseline probe sessions all the participants will be randomly assigned to receive either DTTC-E or DTTC-C in the first 6-week treatment phase Then the between-treatment probe sessions will be conducted during a 2-week washout period This will be followed by the second 6-week treatment phase which will be the other version of DTTC Post-treatment probe sessions will be conducted one week and one month after completion of the second treatment
Participants speech productions will be transcribed and evaluated based on their accuracy in phonemes stress and tone Growth curve analysis Mirman 2014 will be conducted to examine the group differences in the outcome measures across the treatment sessions
Participants speech productions will be transcribed and evaluated based on their accuracy in phonemes stress and tone Growth curve analysis Mirman 2014 will be conducted to examine the group differences in the outcome measures across the treatment sessions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None